Clinical trial
Correlating Renal Cell Cancer Treatment Efficacy With Sunitinib Therapeutic Levels and Outcomes
NCT01711268 is registered in ClinicalTrials.gov with Western Sydney Local Health District as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Correlating Renal Cell Cancer Treatment Efficacy With Sunitinib Therapeutic Levels and Outcomes
- Lead sponsor
- Western Sydney Local Health District
- Phase
- Observational
- Overall status
- Unknown status
- Start date
- May 31, 2012
- Completion date
- December 31, 2014
- Enrollment
- 35 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
renal cell carcinoma